Onno van de Stolpe (born 25 October 1959,

Geldrop Geldrop is a town in the Dutch province of North Brabant. It is in the municipality of Geldrop-Mierlo, around 5 km east of Eindhoven city centre. Geldrop was a separate municipality until 2004, when it merged with Mierlo. Geldrop is noted ...

) is a Dutch businessman and is currently CEO of

Galapagos NV Galapagos NV (formerly known as Galapagos Genomics) is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston a ...

, a drug discovery and development company. He will retire in April 2022.

Education

Van de Stolpe obtained an MSc degree from the Agricultural University in

Wageningen Wageningen () is a municipality and a historic city in the central Netherlands, in the province of Gelderland. It is famous for Wageningen University, which specialises in life sciences. The municipality had a population of in , of which many ...

(the Netherlands).

Career

Van de Stolpe began his career as Manager Business Development at MOGEN in Leiden. Afterwards, he worked for the

Netherlands Foreign Investment Agency Netherlands Foreign Investment Agency (NFIA) is an operational unit of the Dutch Ministry of Economic Affairs. It assists foreign companies wishing to establish their business in the Netherlands and to take advantage of the Dutch business environm ...

in California, where he was responsible for recruiting biotech and medical device companies to locate in the Netherlands. When he returned to The Netherlands, Van de Stolpe founded Galapagos NV in 1999 when he was recruited by the CEO of

Crucell Janssen Vaccines, formerly Crucell, is a biotechnology company specializing in vaccines and biopharmaceutical technologies. It was formed when Johnson & Johnson acquired the Dutch biotech company Crucell based in Leiden and placed it in their ph ...

to set up a new genomics division for the company. He launched the division in a join venture with

Tibotec Tibotec was a pharmaceutical company with a focus on research and development for the treatment of infectious diseases such as HIV/AIDS and hepatitis C. The company was founded in 1994 and then acquired by Johnson & Johnson and merged into its J ...

. Since its inception, Van de Stolpe has grown Galapagos NV to almost 600 employees and is one of the largest biotechs in Europe by market cap.

Sources

De Nederlandse durfal van Galapagos

Galapagos sluit overeenkomst met Eli Lilly

References

1959 births Living people Dutch corporate directors Dutch businesspeople Dutch chief executives People from Geldrop Wageningen University and Research alumni 20th-century Dutch people {{Netherlands-business-bio-stub